Insider · CIK 0001873522
Jennifer Fulk
Files at KURA (Kura Oncology, Inc.), SLNO (SOLENO THERAPEUTICS INC). First filing -, latest -.
Jennifer Fulk files SEC Form 4 as CFO at KURA (Kura Oncology, Inc.), and also at SLNO (SOLENO THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jennifer Fulk has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative10b5-1 | +450,000 | $0.00 | $0 | 450,000 | 33 d ago |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Common Stock | -39,200 | - | - | 0 | May 18, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -67,660 | - | - | 0 | May 18, 2026 |
| Mar 2, 2026 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Common Stock | +39,200 | $0.00 | $0 | 39,200 | Mar 4, 2026 |
| Mar 2, 2026 | SLNO SOLENO THERAPEUTICS INC | MOption exercise Employee stock option (right to buy)derivative | +67,660 | $0.00 | $0 | 67,660 | Mar 4, 2026 |
Questions about Jennifer Fulk
Answered from the filings on this page, as of the latest one.
Is Jennifer Fulk buying or selling?
Jennifer Fulk has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jennifer Fulk's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer Fulk has 0.
Where does Jennifer Fulk file Form 4?
Jennifer Fulk has filed Form 4 at KURA (Kura Oncology, Inc.) as Chief Financial Officer; SLNO (SOLENO THERAPEUTICS INC) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.